Csenge Advisory Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Csenge Advisory Group’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-30	Closed	–	–	1615
2018 Q3	$0	Buy	+30	New	+$649	﹤0.01%	1743

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Csenge Advisory Group's SPPI Position: Q4 2018 in Review

Csenge Advisory Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2018, closing a stake of 30 shares.

Csenge Advisory Group first reported a position in SPPI in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 176 funds tracked by Wall St. Rank hold SPPI as of Q4 2018.

Csenge Advisory Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 30 Spectrum Pharmaceuticals Inc shares in Q4 2018.
Csenge Advisory Group first reported a position in Spectrum Pharmaceuticals Inc in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's Spectrum Pharmaceuticals Inc position peaked at $0 in Q3 2018.
176 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.